Study: CBD Reduces Airway Inflammation and Fibrosis in Experimental Allergic Asthma.
The Joint Blog
DECEMBER 2, 2018
According to a new study published by the European Journal of Pharmacology , and epublished by the U.S. National Institute of Health , cannabidiol (CBD) reduces airway inflammation and fibrosis in experimental allergic asthma. “Asthma remains a major public health problem and, at present, there are no effective interventions capable of reversing airway remodelling”, states the study’s abstract. “Cannabidiol (CBD) is known to exert immunomodulatory effects through the acti
38 
Let's personalize your content